๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Darbepoetin Alfa Treatment for Post-Renal Transplantation Anemia During Pregnancy

โœ Scribed by Janet Goshorn; Timothy D. Youell

Book ID
114467204
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
165 KB
Volume
46
Category
Article
ISSN
0272-6386

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Randomized trial of darbepoetin alfa for
Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients
โœ Vanrenterghem, Yves; Bรƒยกrรƒยกny, Peter; Mann, Johannes F.E.; Kerr, Peter G.; Wilso ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 601 KB

## Background: Darbepoetin alfa is a glycoprotein with a three-fold longer terminal half-life than recombinant human erythropoietin (rhuepo). we aimed to determine whether darbepoetin alfa is as effective and well tolerated as rhuepo for treating renal anemia in dialysis patients when administered

A randomized, active-control, pilot tria
A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease
โœ John A. Glaspy; Jaswant Sinh Jadeja; Glen Justice; Alex Fleishman; Gregory Rossi ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 123 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND Anemia in patients receiving chemotherapy can be ameliorated with recombinant human erythropoietin (rHuEPO), which is administered one to three times per week. Darbepoetin ฮฑ, a new erythropoietic agent, has longer serum residence time, allowing it to be administered less